Hypocalcemia / Milk Fever (acute)

Hypocalcemia, commonly known as milk fever or parturient paresis, is an acute metabolic emergency occurring in dairy cattle and other ruminants when blood calcium levels drop to dangerously low levels around the time of calving. Despite the misleading common name, this condition involves neither fever nor mammary gland infection, but rather a critical shortage of calcium in the bloodstream that impairs normal neuromuscular function throughout the body. The sudden massive demand for calcium to produce colostrum and milk at the onset of lactation overwhelms the body's ability to mobilize calcium from bones and absorb it from the diet, resulting in a potentially fatal metabolic crisis.

Milk fever primarily affects dairy cattle, with the highest incidence occurring in high-producing cows entering their third or subsequent lactations. The condition affects an estimated 5 to 10 percent of dairy cows in affected herds, though subclinical hypocalcemia (low blood calcium without obvious clinical signs) may affect 50 percent or more of periparturient dairy cows. Sheep and goats also develop hypocalcemia, typically in late pregnancy when fetal calcium demands are highest, a condition often called pregnancy toxemia or twin lamb disease when combined with energy deficiency. The timing and presentation differ somewhat between species, but the underlying calcium deficiency and resulting neuromuscular dysfunction are similar.

The economic and welfare impact of hypocalcemia extends far beyond the immediate emergency. Direct costs include treatment expenses, veterinary fees, and mortality losses in severe cases. Indirect costs are substantial and include increased risk of numerous secondary conditions including displaced abomasum, retained placenta, metritis, mastitis, and ketosis. Cows affected by hypocalcemia have reduced milk production throughout lactation, impaired fertility, and increased risk of culling. The immunosuppressive effects of low calcium contribute to increased disease susceptibility during the critical early lactation period. Estimates suggest hypocalcemia costs the dairy industry hundreds of millions of dollars annually in the United States alone.

Recognition of early clinical signs and immediate treatment with intravenous calcium are essential for successful outcomes in milk fever cases. The classic presentation of a recently calved cow unable to rise is unmistakable, but earlier detection allows treatment before the animal becomes recumbent and at risk for secondary complications. Prevention strategies targeting calcium metabolism around calving have dramatically reduced milk fever incidence in herds implementing these approaches and represent the most cost-effective approach to this common and costly condition.

The primary cause of acute hypocalcemia is the sudden dramatic increase in calcium demand that occurs at the onset of lactation. A high-producing dairy cow may secrete 20 to 30 grams of calcium in colostrum on the first day of lactation, representing several times the total amount of calcium circulating in her bloodstream. This calcium must come from either intestinal absorption or mobilization from bone reserves. In older cows and those with inadequate adaptation to this demand, blood calcium levels plummet as the mammary gland extracts calcium faster than it can be replaced. When blood calcium falls below approximately 5.5 mg/dL (normal is 8.5-10.5 mg/dL), clinical signs begin to appear.

Genetic and individual animal factors significantly influence hypocalcemia susceptibility. High milk production is a major risk factor, as greater milk volume means greater calcium output. Jersey and Guernsey breeds appear more susceptible than Holsteins, possibly due to higher milk calcium concentrations. Age is a critical factor, with cows in their third or later lactation at highest risk because their calcium absorption and mobilization systems become less responsive over time. Body condition at calving influences risk, with both overconditioned and underconditioned cows at elevated risk. Individual variation in calcium metabolism efficiency creates cow-to-cow differences in susceptibility within herds.

Dietary and management factors during the dry period profoundly affect hypocalcemia risk at calving. Diets high in potassium, which is common in many forages, create a metabolic alkalosis that impairs the cow's ability to mobilize bone calcium reserves. Excessive dietary calcium during the dry period paradoxically increases milk fever risk by suppressing the hormonal systems that mobilize calcium. Inadequate dietary magnesium impairs calcium metabolism and increases hypocalcemia risk. The length and management of the dry period affect metabolic preparation for lactation. Stress around calving including transportation, housing changes, or environmental extremes can trigger or worsen hypocalcemia.

Several specific risk factors compound hypocalcemia risk and should be identified for preventive management. History of previous milk fever dramatically increases risk in subsequent lactations. Cows carrying twins or triplets have higher fetal calcium demands and increased risk. Calving difficulty and other periparturient stresses compound metabolic challenges. Hot weather appears to increase milk fever incidence. Concurrent disease, particularly those causing anorexia, reduces calcium intake and absorption. Short dry periods may not allow adequate metabolic preparation.

The pathophysiology of hypocalcemia involves failure of the normal calcium homeostatic mechanisms to meet sudden increased demand. Parathyroid hormone (PTH) normally responds to falling blood calcium by increasing bone calcium mobilization and kidney calcium retention. The active form of vitamin D (1,25-dihydroxyvitamin D) increases intestinal calcium absorption. However, these systems require hours to days to fully activate, and in cows that are not properly adapted, the lag time allows blood calcium to fall to dangerous levels. The resulting hypocalcemia impairs neuromuscular function throughout the body because calcium is essential for muscle contraction and nerve signal transmission. Smooth muscle dysfunction affects the gastrointestinal tract, reducing rumen motility and appetite. Skeletal muscle weakness progresses to recumbency. Cardiac muscle is also affected, with potentially fatal arrhythmias in severe cases.

Early warning signs of hypocalcemia may be subtle and easily missed without careful observation of periparturient animals. Stage I milk fever involves mild symptoms as blood calcium begins to fall below normal. Affected cows show subtle signs of agitation or excitability, may appear anxious or nervous, and often exhibit fine muscle tremors, particularly visible over the flanks and shoulders. Appetite decreases, and cows may be reluctant to eat grain despite maintaining interest in hay. Milk production drops or the cow is difficult to milk due to reduced udder letdown. Ears may feel cool to the touch, and the muzzle may be dry. Subtle gait abnormalities including stiffness or slight incoordination may be apparent to observant caretakers.

As hypocalcemia progresses to Stage II, symptoms become unmistakable and the cow's condition deteriorates significantly. The cow becomes unable to stand and assumes the classic milk fever posture, lying on her sternum with head turned into the flank (S-curve of the neck). The muzzle becomes dry, and body temperature typically drops below normal (hypothermia) despite the term fever in the common name. Heart rate increases but heart sounds become muffled, and the pulse quality decreases. Pupils become dilated and the cow appears dull and unresponsive. Rumen motility ceases, leading to bloat as gas accumulates. Constipation develops as intestinal motility fails. The cow may strain as if attempting to urinate or defecate but produces little.

Species-specific presentations occur in sheep, goats, and other affected animals. In sheep, hypocalcemia typically occurs in late pregnancy rather than immediately after lambing, especially in ewes carrying multiple fetuses. Signs include hind limb weakness progressing to recumbency, bloat, teeth grinding, and altered mental status. Goats show similar patterns to sheep. In all species, hypocalcemia may occur concurrently with or be mistaken for other periparturient conditions including pregnancy toxemia (in small ruminants) and other metabolic diseases.

Physical examination findings in Stage II hypocalcemia are characteristic and help differentiate this condition from other causes of recumbency. Temperature is typically subnormal, often 36-37°C (96-99°F) rather than the normal 38.5°C (101°F). Heart rate is elevated to 80-100+ beats per minute with decreased intensity of heart sounds. Rumen contractions are absent on auscultation and ballottement. The cow is alert enough to resist handling but cannot stand despite attempts. Pupils are dilated. Muscle tone is markedly decreased. The characteristic head-into-flank position, if present, is highly suggestive of hypocalcemia.

Symptom progression to Stage III represents a life-threatening emergency requiring immediate intervention. The cow becomes laterally recumbent (lying flat on her side) rather than sternally recumbent, indicating complete loss of muscle function. She becomes comatose and unresponsive to stimulation. Heart rate becomes very rapid and irregular as cardiac muscle function fails. Bloat becomes severe and may cause respiratory compromise due to pressure on the diaphragm. Body temperature continues to fall. Without treatment, death occurs within hours from cardiovascular collapse, respiratory failure, or aspiration pneumonia.

Certain symptoms warrant immediate emergency response. Lateral recumbency indicates severe hypocalcemia requiring immediate calcium administration. Severe bloat in a recumbent cow may require emergency relief. Complete unresponsiveness suggests Stage III milk fever with poor prognosis without immediate treatment. Concurrent signs of calving difficulty or other emergency conditions compound the urgency. Any downer cow around calving should be evaluated for hypocalcemia, as prompt treatment can be lifesaving while delays dramatically worsen prognosis.

Clinical diagnosis of milk fever is often straightforward based on the classic presentation and timing. A recently calved dairy cow in her third or later lactation presenting with weakness, recumbency, hypothermia, and absent rumen motility is presumptively diagnosed with hypocalcemia and treated accordingly. The dramatic response to calcium therapy within minutes to hours serves as both treatment and diagnostic confirmation. However, atypical presentations, concurrent diseases, and cows that fail to respond as expected require more thorough diagnostic investigation.

Diagnostic testing confirms hypocalcemia and identifies complicating factors. Blood calcium measurement is definitive, with clinical milk fever typically associated with serum calcium levels below 5.5 mg/dL and often below 4.0 mg/dL. However, results are rarely available quickly enough to guide initial treatment decisions, so therapy is typically initiated based on clinical signs. Concurrent measurement of phosphorus and magnesium is valuable because these minerals are frequently abnormal in milk fever cases and failure to address concurrent hypomagnesemia or hypophosphatemia may explain poor treatment response. Blood glucose measurement helps identify concurrent ketosis. Muscle enzyme levels (CK, AST) indicate the degree of muscle damage from recumbency.

Differential diagnosis considers other conditions causing periparturient recumbency in dairy cattle. Toxic mastitis can cause profound weakness and recumbency but typically includes udder changes and fever rather than hypothermia. Metritis may cause depression and anorexia but usually develops several days after calving. Traumatic injuries from calving including nerve damage, hip luxation, or muscle tears cause recumbency but lack the metabolic changes of hypocalcemia. Ketosis causes depression and anorexia but recumbency is less common. Concurrent conditions are common, and milk fever cows frequently have ketosis, retained placenta, or other complications that complicate diagnosis and management.

Herd-level diagnostic assessment is valuable when milk fever incidence is elevated. Review of dry cow nutrition identifies dietary risk factors including high potassium, excessive calcium, or inadequate magnesium. Analysis of forage mineral content guides ration reformulation. Evaluation of body condition scores at calving identifies over- or under-conditioning. Assessment of calving management and facilities identifies stressors that may contribute to metabolic disease. Blood calcium monitoring of fresh cows, either individual animals or herd-level sampling, quantifies the magnitude of subclinical hypocalcemia in the herd and guides prevention program adjustments.

Emergency treatment of clinical milk fever requires immediate intravenous calcium administration to restore neuromuscular function before irreversible complications develop. The standard treatment is intravenous infusion of calcium borogluconate or calcium gluconate solution, typically providing 8 to 12 grams of elemental calcium per treatment. The calcium solution must be administered slowly over 10 to 20 minutes while monitoring heart rate, as overly rapid administration can cause fatal cardiac arrhythmias. The cow's heart should be auscultated throughout infusion, and the rate slowed or stopped if significant arrhythmias develop. Response to treatment is often dramatic, with the cow beginning to show improved alertness, muscle tone, and rumen motility within minutes of completing the infusion.

Medical management extends beyond the initial calcium bolus to prevent relapse and address concurrent conditions. Approximately 25 to 30 percent of cows treated for milk fever will relapse within 24 to 72 hours as blood calcium drops again with ongoing milk production. Subcutaneous calcium administration following or instead of intravenous treatment provides slower, sustained calcium absorption that may reduce relapse risk. Oral calcium supplements, typically calcium propionate or calcium chloride gels or boluses, provide additional calcium and can be given by farm personnel at first signs of relapse. Concurrent treatment with phosphorus and magnesium supplements addresses these common concurrent deficiencies. Treatment for ketosis is frequently indicated in milk fever cows.

Supportive care is essential for optimal outcomes, particularly in Stage II and III cases where cows have been recumbent. The cow should be positioned on a well-bedded surface with good footing to facilitate rising once neuromuscular function returns. Rolling the cow from side to side every few hours prevents muscle and nerve damage from prolonged pressure on one side. Propping in sternal recumbency is preferable to lateral recumbency. If the cow cannot rise within several hours of treatment, evaluation for secondary complications including nerve damage or muscle injury is indicated. Bladder catheterization may be needed if the cow cannot urinate. Prevention of aspiration pneumonia by keeping the head elevated is important for unconscious or weakly responsive cows.

Monitoring during and after treatment guides ongoing management. Heart rate and rhythm should be monitored throughout intravenous calcium infusion. Response to treatment is assessed by observing return of alertness, muscle tone, rumen motility, and ability to rise. Temperature should be monitored with rewarming measures implemented for severely hypothermic cows. Repeat blood calcium measurement 12 to 24 hours after treatment identifies cows at high relapse risk. Fresh cows that have had milk fever should be monitored closely for several days for signs of relapse or development of secondary conditions.

Herd treatment considerations arise when multiple fresh cows are affected or at risk. Prophylactic oral calcium supplementation of all cows at calving is commonly practiced in herds with high milk fever incidence. Postpartum monitoring protocols ensure early detection and treatment of affected cows. Evaluation and modification of dry cow nutrition is essential for long-term reduction in milk fever incidence.

Treatment decisions should consider the cow's response to therapy and likelihood of recovery. Most cows with uncomplicated milk fever respond well to treatment and return to normal production. Cows that remain recumbent despite appropriate treatment may have secondary complications or concurrent conditions requiring additional diagnostics and treatment. The downer cow syndrome, in which cows remain unable to rise for extended periods, carries progressively worsening prognosis and quality of life considerations. Euthanasia is appropriate for cows that develop severe secondary complications, fail to respond to aggressive treatment, or are unable to rise after several days despite appropriate care.

Recovery from uncomplicated milk fever is typically rapid and complete when treatment is prompt and appropriate. Most cows that receive calcium treatment before Stage III begin to improve within 30 to 60 minutes and are standing within 2 to 4 hours. Full recovery of appetite, rumen function, and milk production occurs over 24 to 48 hours in straightforward cases. However, recovery is significantly complicated when cows have been recumbent for extended periods or have developed secondary conditions during the hypocalcemic episode.

Post-treatment care focuses on preventing relapse and monitoring for complications. Cows should be observed frequently for the first 24 to 48 hours for signs of recurring weakness or recumbency. Oral calcium supplementation is typically continued for 24 to 48 hours after initial treatment to provide ongoing calcium support during the period of highest relapse risk. Feed intake should be monitored with intervention for cows that remain off feed. Milk production initially remains below expected levels and gradually returns to normal over several days. Monitoring for secondary conditions including displaced abomasum, ketosis, retained placenta, and metritis guides ongoing management during the early lactation period.

Prognosis varies with the severity of the hypocalcemic episode and presence of complications. Cows treated in Stage I or early Stage II have excellent prognosis with near-complete recovery expected. Stage III cases have more guarded prognosis due to the severity of metabolic derangement and increased risk of secondary complications. Cows that remain recumbent for more than several hours despite treatment often have muscle or nerve damage that significantly impacts recovery. The downer cow syndrome, defined as inability to rise for more than 24 hours despite treatment, carries poor long-term prognosis with many affected cows requiring euthanasia despite intensive nursing care.

Return to production following milk fever requires balancing recovery needs against economic pressures. Cows that recover promptly can return to normal milking immediately, though milk production may remain below expected levels for the first week or more of lactation. Cows with complicated recoveries may require reduced milking frequency or partial milk-out to reduce calcium demands while recovery progresses. Breeding should be delayed if recovery is prolonged or if secondary reproductive tract conditions develop. The significantly increased risk of displaced abomasum, ketosis, and other early lactation diseases in cows that have had milk fever warrants heightened monitoring throughout early lactation. Documentation of milk fever episodes guides culling decisions and genetic selection to reduce future incidence.

Prevention of milk fever through manipulation of dry cow nutrition has revolutionized management of this condition in modern dairy herds. The most effective approach involves feeding anionic salts during the close-up dry period (typically the last 2 to 3 weeks before calving) to induce a mild metabolic acidosis that activates calcium mobilization systems before calving. This approach, known as DCAD (Dietary Cation-Anion Difference) management, can reduce milk fever incidence by 50 to 80 percent in herds with significant problems. Monitoring urine pH confirms appropriate dietary acidification. Alternative approaches include restricting dietary calcium during the dry period to stimulate calcium mobilization, though this is more difficult to achieve with common feedstuffs.

Biosecurity considerations for milk fever prevention focus on management systems that minimize periparturient stress. Calving facilities should provide comfortable, low-stress environments. Separating close-up dry cows from the main herd allows specialized nutrition and monitoring. Minimizing group changes and social disruption during the transition period reduces stress-related metabolic challenges. Avoiding transportation and other major stressors near calving time protects high-risk animals.

Nutritional management during the dry period is the cornerstone of milk fever prevention. Potassium levels in forages should be monitored and high-potassium feeds avoided or limited in dry cow diets. Dietary magnesium must be adequate to support calcium metabolism. Excessive calcium in dry cow diets should be avoided except when using acidifying strategies. Vitamin D metabolism can be supported through appropriate supplementation. Feed intake during the close-up period should be optimized to ensure cows consume intended rations. Body condition management prevents both over- and under-conditioning at calving.

Management practices complement nutritional strategies for comprehensive milk fever prevention. Oral calcium supplementation at calving provides immediate calcium support during the highest-risk period and is now widely recommended for all cows in high-risk categories. Postpartum monitoring programs ensure early detection of hypocalcemia for prompt treatment. Culling or careful management of repeat offenders reduces herd incidence over time. Heat stress management during late summer helps reduce the seasonal increase in milk fever risk seen in many herds.

Genetic considerations play an increasing role in milk fever prevention. Heritability estimates for milk fever susceptibility suggest selective breeding can reduce incidence over generations. Bull selection using estimated breeding values for health traits, where available, allows gradual genetic improvement. Within-herd identification of high-risk cow families guides culling and breeding decisions. Breed selection may be relevant for some operations, with some breeds appearing less susceptible than others.

Daily management during the transition period centers on close observation and early intervention for cows showing signs of hypocalcemia. Fresh cows should be observed multiple times daily, with attention to appetite, alertness, gait, and general demeanor. Reduced feed intake, stiffness, or reluctance to rise are early warning signs warranting closer evaluation. Body temperature should be monitored in fresh cows, with subnormal temperature prompting suspicion of hypocalcemia. Prompt treatment of cows showing early signs prevents progression to recumbency and associated complications.

Housing and environmental management for transition cows supports metabolic health and early detection of problems. Calving areas should provide comfortable, clean, well-bedded surfaces that facilitate observation and treatment. Fresh cow housing should allow easy monitoring while minimizing stress from overcrowding or social competition. Adequate feed bunk space ensures all cows can eat without competition, which is especially important for cows with reduced appetite or energy. Heat stress management during warm weather helps reduce the additional metabolic burden on transition cows.

Herd health programs should include comprehensive milk fever prevention and management protocols. Written protocols for dry cow nutrition specify target DCAD levels, mineral supplementation, and feeding management. Monitoring systems including urine pH testing verify that dietary acidification is achieving desired results. Fresh cow protocols specify observation schedules, criteria for intervention, and treatment procedures. Staff training ensures all personnel can recognize early hypocalcemia signs and initiate appropriate response. Veterinary involvement in protocol development and periodic review optimizes program effectiveness.

Record keeping supports milk fever management through documentation of individual cow events and herd-level trends. Individual cow records track previous milk fever episodes, treatment responses, and secondary complications to guide management of at-risk individuals. Herd-level monitoring of milk fever incidence identifies trends requiring nutritional or management intervention. Feed and nutrition records document dry cow ration composition and changes. These records support continuous improvement of prevention programs and provide valuable information for troubleshooting when milk fever incidence increases.

Economic considerations for milk fever management extend beyond direct treatment costs to include the substantial indirect impacts of this condition. Prevention programs involving specialized dry cow nutrition require investment in ration formulation, potentially different feedstuffs, and monitoring. However, the return on this investment is typically strongly positive given the high costs of clinical milk fever and the even greater economic impact of subclinical hypocalcemia on early lactation health and productivity. Cost-benefit analysis guides decisions about prevention program intensity based on herd-specific milk fever risk and incidence.

Milk fever risk varies significantly among dairy cattle breeds, with Jersey and Guernsey cows appearing most susceptible and Holstein cows also frequently affected. The higher susceptibility of Jersey and Guernsey cows may relate to their higher milk calcium concentrations, which increases calcium output at calving. Within breeds, high-producing individuals face greater risk due to their greater milk and calcium output. Age is one of the strongest risk factors, with cows in their third or later lactation at dramatically higher risk than first-lactation animals. The combination of high genetic merit for milk production and advancing age creates the highest-risk category.

Production type and management intensity influence milk fever occurrence patterns. High-producing commercial dairy herds face the greatest challenges, with subclinical hypocalcemia affecting the majority of fresh cows in many herds. Beef cattle rarely develop classic milk fever due to their lower milk production, though hypocalcemia can occur in beef cows with heavy milking genetic influence or those nursing multiple calves. Sheep and goats typically develop hypocalcemia in late pregnancy rather than immediately postpartum, with animals carrying multiple fetuses at highest risk. Intensive dairy goat and sheep operations face similar challenges to dairy cattle operations.

Genetic selection and testing for milk fever resistance is an emerging area in dairy cattle breeding. Heritability estimates suggest that selective breeding can gradually reduce milk fever susceptibility within herds and breeds. Genetic evaluations for health traits including hypocalcemia are increasingly available from breeding organizations. Within-herd selection against cows with repeated milk fever episodes reduces genetic risk over generations. However, the strong positive genetic correlation between high milk production and milk fever susceptibility means that selection for reduced susceptibility must be balanced against production goals. Management and nutritional prevention strategies remain essential even in herds implementing genetic selection.

Several conditions commonly co-occur with or develop as sequelae to hypocalcemia in dairy cattle. Displaced abomasum is three to eight times more common in cows that have had clinical or subclinical hypocalcemia, likely due to the effects of low calcium on abomasal motility. Retained placenta incidence is significantly elevated in hypocalcemic cows because uterine muscle contraction required for placental expulsion depends on adequate calcium. Metritis frequently follows retained placenta and is more common in hypocalcemic cows even without retained placenta. Ketosis commonly accompanies or follows milk fever due to reduced feed intake and metabolic disruption. Mastitis incidence is increased in hypocalcemic cows, possibly related to immune system effects of low calcium and effects on teat sphincter function.

Conditions with similar presentations must be differentiated from hypocalcemia for appropriate treatment. Toxic mastitis causes weakness and depression but typically includes udder abnormalities and fever rather than hypothermia. Severe metritis can cause depression and weakness but usually develops several days after calving and includes fever and uterine discharge. Nerve damage from calving, particularly to the obturator or sciatic nerves, causes hind limb weakness or paralysis but lacks the generalized weakness and metabolic changes of hypocalcemia. Traumatic injuries including hip luxation and muscle tears cause inability to rise but are typically more localized. Concurrent conditions are common, and thorough evaluation identifies cows requiring treatment for multiple problems.

Complications and sequelae of hypocalcemia significantly impact cow welfare and productivity beyond the immediate metabolic crisis. The downer cow syndrome develops when cows remain recumbent for extended periods, with progressive muscle and nerve damage that may become irreversible. Pressure sores and muscle necrosis develop in recumbent cows without adequate nursing care. Aspiration pneumonia can result from reduced swallowing function or inappropriate positioning during recumbency. The increased risk of numerous early lactation diseases in cows affected by hypocalcemia results in substantially reduced productivity and reproductive performance throughout lactation. These wide-ranging effects make prevention of hypocalcemia one of the most important components of transition cow management in dairy herds.